ACTION (NCT04332107) |
Wrong population: study does not specifically include participants with olfactory dysfunction |
Begam 2020 |
Narrative review article, no primary data |
COPPS (NCT04662060) |
Wrong population: study does not specifically include participants with olfactory dysfunction |
Co‐STAR (NCT04422275) |
Although this study fits the inclusion criteria for the review, it was withdrawn prior to any participant enrolment |
COVIDAtoZ (NCT04342728) |
Wrong population: study does not specifically include participants with olfactory dysfunction |
COVIDORL (NCT04361474) |
Wrong population: all participants in the study have had symptoms of olfactory disturbance for at least 4 weeks. This study is relevant for the companion review "Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction" (Webster 2021a). |
CTRI/2020/08/027477 |
Wrong population: study does not specifically include participants with olfactory dysfunction |
IRCT20200522047542N1 |
Wrong population: all participants in the study have had symptoms of olfactory disturbance for at least 4 weeks. This study is relevant for the companion review "Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction" (Webster 2021a). |
NCT04374474 |
Although this study fits the inclusion criteria for the review, it was withdrawn prior to any participant enrolment |
NCT04382547 |
Wrong study design: not a randomised controlled trial |
NCT04406584 |
Wrong population: includes participants with any post‐viral olfactory disturbance (not specifically COVID‐19) |
NCT04414124 |
Wrong population: study does not specifically include participants with olfactory dysfunction |
NCT04427332 |
Wrong study design: observational study, not a randomised controlled trial |
NCT04458519 |
Wrong population: study does not specifically include participants with olfactory dysfunction |
NCT04474483 |
Wrong population: study does not specifically include participants with olfactory dysfunction |
NCT04513184 |
Wrong population and wrong comparator: study does not specifically include participants with olfactory dysfunction; intervention is compared to intravenous dexamethasone |
NCT04622891 |
Wrong population: study does not specifically include participants with olfactory dysfunction |
NCT04662086 |
Wrong population: study does not specifically include participants with olfactory dysfunction |
Odorat‐Covid (NCT04598763) |
Wrong population: all participants in the study have had symptoms of olfactory disturbance for at least 4 weeks. This study is relevant for the companion review "Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction" (Webster 2021a). |
Patel 2021 |
Letter to the editor: no primary data included |
Pinna 2020 |
Letter to the editor: no primary data included |
Vaira 2020 |
Wrong population: all participants in the study have had symptoms of olfactory disturbance for at least 4 weeks. This study is relevant for the companion review "Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction" (Webster 2021a). |
Vroegop 2020 |
Narrative review article: no primary data |